1. Scrip
  2. >>R&D

LifeSpan BioSciences Inc.

 
• By Wendy Diller

Drug Discovery Tools; Genomics. LifeSpan has a high throughput analysis method by which it hopes to identify numerous genes related to diseases common to aging. Initially, the company is researching genes implicated in diseases that cause premature aging; Hutchinson-Gilford syndrome and Werner's syndrome.

In this age of rapid genomic analysis, some believe that Juan Ponce de León's Fountain of Youth may be found in the next gene sequenced. And whoever finds that youth gene is bound to make a fortune on aging baby boomers lusting for their lost nubility.

In fact, the goal of LifeSpan BioSciences Inc. , is not to find one elusive youth gene, but to identify numerous genes related to diseases common to aging. They...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from R&D

More from Scrip

ASCO: J&J Banks On T-Cell Engager’s Safety In Prostate Cancer

 
• By Andrew McConaghie

The company highlighted the KLK2-targeting agent’s safety at ASCO but it may have to rely on combinations to make pasritamig competitive.

ASCO: Regeneron Looks To Become Bigger Immuno-Oncology Player

 
• By Alaric DeArment

The drugmaker presented oral abstracts at the meeting for Libtayo in adjuvant cutaneous squamous-cell carcinoma and linvoseltamab in multiple myeloma.

ASCO: Lupin Presents Early Data On PRMT5 Inhibitor

 
• By Vibha Ravi

ASCO sees the debut of Lupin’s PRMT5 inhibitor candidate LRNP7457, currently in Phase I studies in India. While no drug with this mechanism of action has been approved anywhere so far, several candidates are in clinical trials.